We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Esaote

Esaote is a leading industrial Group with a unique value proposition, providing medical imaging solutions in Ultrasou... read more Featured Products: More products

Download Mobile App




Ultrasound Technology Enhancements Provide Imaging at Greater Depths

By MedImaging International staff writers
Posted on 13 Mar 2014
Print article
Image: Esaote’s CrystaLine range of ultrasound systems (Photo courtesy of Esaote).
Image: Esaote’s CrystaLine range of ultrasound systems (Photo courtesy of Esaote).
New ultrasound technology’s precise technical capabilities enable high quality images to be captured at greater depths in the body. This significant improvement overcomes the difficultly associated with scanning larger and more technically challenging patients.

Esaote (Genoa, Italy), a world-leading developer of medical diagnostic systems, recently introduced CrystaLine range of ultrasound systems, a significant progression of its ultrasound technology that provides new degrees of accuracy, quality, flexibility, and cost-effectiveness.

CrystaLine integrates dedicated hardware and software features that build on the eHD ultrasound technology Esaote introduced in 2013. The higher quality and clearer imaging at increased depth now enables clinicians to effectively use ultrasound in borderline exams and interventional ultrasound procedures.

Carlos Faustmann, Esaote’s chief global marketing and domestic sales officer, clarified, “Ultrasound is highly valued for its safe, noninvasive nature, and continues to evolve and prove its value. One of the challenges has been capturing high quality images in those technically difficult patients. CrystaLine changes all that.”

Key technical enhancements provided by CrystaLine include combined pulse imaging technology, which effectively increases depth-of-field, improving the imaging of structures deeper in the body. Combined with the new XView+ speckle-noise reduction system, fully adjustable by the operator, helps to generate an enhanced customized image.

Esaote systems with CrystaLine are also able to synchronize in real-time with therapeutic applications such as Echolaser to guide laser ablation and other procedures. “CrystaLine enables clinicians to synchronize with interventional systems such as medical lasers,” continued Mr. Faustmann. “This feature plus the introduction of the 0° biopsy-interventional dedicated probe, is an example of the huge potential for Esaote and ultrasound in direct therapeutic applications.”

Esaote Group is a leading player in the biomedical equipment sector, with a specific focus on ultrasound, magnetic resonance, and software for managing the diagnostic process. Esaote has over 1,360 employees, 20% of which are employed in R&D activities.

Related Links:

Esaote


Computed Tomography System
Aquilion ONE / INSIGHT Edition
Digital X-Ray Detector Panel
Acuity G4
X-ray Diagnostic System
FDX Visionary-A
New
Leg Wraps
Leg Wraps

Print article

Channels

MRI

view channel
Image: An AI tool has shown tremendous promise for predicting relapse of pediatric brain cancer (Photo courtesy of 123RF)

AI Tool Predicts Relapse of Pediatric Brain Cancer from Brain MRI Scans

Many pediatric gliomas are treatable with surgery alone, but relapses can be catastrophic. Predicting which patients are at risk for recurrence remains challenging, leading to frequent follow-ups with... Read more

Nuclear Medicine

view channel
Image: In vivo imaging of U-87 MG xenograft model with varying mass doses of 89Zr-labeled KLG-3 or isotype control (Photo courtesy of L Gajecki et al.; doi.org/10.2967/jnumed.124.268762)

Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors

Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.